Federal contract award
75N91023F00015
FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N91019D00024 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $16.4M |
| Current contract value | $16.4M |
| Potential contract value / ceiling | $16.4M |
| Start date | Sep 27, 2023 |
| Current end date | Jun 18, 2026 |
| Potential end date | Jun 18, 2026 |
| Latest award activity | Mar 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 4, 2026 | P00006 | $-136.8K | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| Dec 22, 2025 | P00005 | $0 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| Apr 23, 2025 | P00004 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| Mar 13, 2025 | P00003 | $0 | FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION MOD 001 |
| Aug 14, 2024 | P00002 | $888.7K | FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION MOD 001 |
| Mar 21, 2024 | P00001 | $0 | FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION MOD 001 |
| Sep 27, 2023 | 0 | $15.6M | FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.